
POET Technologies Reports Third Quarter 2023
Financial Results
TORONTO, Ontario, November 16, 2023 --
InvestorsHub NewsWire -- POET Technologies Inc.
("POET" or the "Company") (TSX Venture: PTK; NASDAQ:
POET), the designer and developer of the POET Optical
Interposerâ„¢, Photonic Integrated Circuits (PICs) and light sources
for the data center, tele-communication and artificial intelligence
markets, today reported its unaudited consolidated financial
results for the third quarter ended September 30, 2023. The
Company's financial results as well as the
Management Discussion and Analysis have been filed on SEDAR+ and
are available on the SEC's EDGAR website (www.sec.gov/EDGAR). All
financial figures in this press release are in United States
dollars unless otherwise indicated.
Business Highlights since Second Quarter
Results reported on August 11, 2023:
On August
9, 2023, the Company filed a registration statement on Form F-3
with the United States Securities and Exchange Commission
("SEC"). The Form F-3 replaces the Company's expired Form
F-10. Declared effective by the SEC on August 18, 2023, the
Form F-3 may be used to sell securities registered under U.S.
securities laws.
On August
15, 2023, the Company announced the development of an Optical
Interposer platform specifically designed for pluggable1.6T
transceivers, expandable to 3.2T, utilizing current industry form
factors and employing 200G per lane technology for data centers
running artificial intelligence networks.
On
September 1, 2023, the Company announced a resumed ATM program in
the United States with Craig-Hallum Capital Group LLC as its sales
agent, replacing its previous ATM program in the United States and
Canada (please refer to the press release of the same date that
references the registration statement and shelf prospectus
pertaining to the ATM program).
Between
September 6th and 8th, 2023, the Company and its JV, Super
Photonics Xiamen (SPX), showed live demonstrations of end-to-end
optical solutions for 800G, 400G, and 200G transceivers using
POET's highly integrated optical engines at the China International
Optoelectronics Expo (CIOE) in Shenzhen, China. The demonstrations
also featured an 800G transceiver module incorporating a POET 800G
receive engine that Luxshare-ICT intends to market globally. POET
also showcased its own prototype 400G module at the event.
On
September 12, 2023, POET reported on the success of its joint
appearance at the CIOE with SPX and its engagement with multiple
prospective customers for POET optical engines, ranging in speeds
from 100G to 800G. POET's optical engines enable module makers to
lower both labor and capital costs, and provide a seamless path to
higher speeds and more efficient network architectures, while
reducing customers' own in-house R&D efforts.
On October
5, 2023, POET reported that SPX had committed to expand production
capacity needed to fulfill existing and expected customer
orders. SPX is preparing to ramp production of POET's optical
engines.
On October
10, 2023, POET announced a collaboration with Yuanjie Semiconductor
Technology Inc. (YST), to supply SPX with YST's high-performance
directly modulated lasers (DMLs) for use in the 100G and 200G
optical engines being sold to module makers in China and the United
States, including to ADVA, BFYY and Fibertop, and others to be
announced.
On October
13, 2023, POET reported that it had sold an aggregate of 227,673
common shares of the Company on the TSX Venture Exchange and the
Nasdaq Capital Market at an average price of US$4.37 (C$5.82) per
Share, receiving net proceeds from its ATM program in the United
States and Canada of approximately US$983,194 (C$1,285,195) during
the fiscal quarter ended September 30, 2023, and that it had not
sold any common shares under the revised US-only ATM Program from
its inception on September 1, 2023 through September 30,
2023.[SAA1]
On November
2, 2023, POET announced an underwritten public offering in the
United States and a concurrent offering in Canada under the LIFE
exemption (see press release of the same date for additional
information).
On November
6, 2023, the Company provided a financial update that included
preliminary, unaudited financial data in advance of this press
release.
Management Comments
"The third quarter of 2023 has been particularly intensive with
prospect meetings following CIOE, continued support of customers
with module design and qualification, and our financing efforts"
said Dr. Suresh Venkatesan, Chairman & CEO. "Supporting module
design and assembly for optical engine customers in China has been
the principal focus of much of our engineering resources, but soon
those efforts will be behind us and we can look forward to SPX
fulfilling production orders with expanded capacity. In the
US, we are sharply focused on the market for Artificial
Intelligence hardware, which encompasses both leading-edge,
high-speed 800G and 1.6T transceivers, and light sources for
disaggregated network architectures in AI. These two market
segments are expected to yield direct revenue to POET in the form
of NRE for custom designs, sampling and initial module production,
particularly in light sources for AI. We are confident in POET's
value proposition and competitive advantage in these market
segments, especially in pluggables at 1.6T and 3.2T,
high-performance light sources for light-enabled data transmission
in AI servers, and for co-packaged optics. 2024 should set
the stage for what we expect will be accelerated growth in 2025 and
2026, driven by a projected demand in high-speed transceivers,
combined with our innovative product introduction
roadmap."
This news release does not constitute an
offer to sell or the solicitation of an offer to buy, nor shall
there be any sale of common shares or warrants in any jurisdiction
in which such offer, solicitation or sale would be unlawful prior
to the registration or qualification, or an exemption from
registration or qualification, under the securities laws of any
such jurisdiction.
Financial Summary
The Company reported a net loss of $5.1 million, or ($0.13) per
share, in the third quarter of 2023 compared with a net loss $4.0
million, or ($0.11) per share, for the same period in 2022 and a
net loss of $4.4 million, or ($0.11) per share, in the second
quarter of 2023. The net loss in the third quarter of 2023 included
research and development costs of $2.0 million compared to $1.9
million for the same period in 2022 and $2.0 million in the second
quarter of 2023. Fluctuations in R&D for a company of this size
and this stage of growth is expected on a period-over-period basis
as the Company transitions from technology development to product
development.
Non-cash expenses in the third quarter of 2023 included stock-based
compensation of $1.3 million and depreciation and amortization of
$0.5 million. Non-cash stock-based compensation and depreciation
and amortization in the same period of 2022 were $0.9 million and
$0.3 million, respectively. Second quarter 2023 stock-based
compensation and depreciation and amortization were $0.7 million
and $0.5 million, respectively. The Company had non-cash finance
costs of $18,000 in the third quarter of 2023 compared to non-cash
finance costs of $12,000 in the third quarter of 2022 and non-cash
costs of $11,000 in the second quarter of 2023.
The Company recognized other income, including interest of $45,000
in the third quarter of 2023, compared to $57,000 in the same
period in 2022 and $57,000 in the second quarter of 2023.
Non-cash impact of the Company's joint venture, Super Photonics
Xiamen ("SPX"), in the third quarter of 2023 was nil, compared to a
net gain of $0.1 million in the same period of 2022 and nil in the
second quarter of 2023. The Company's share
of loss is approximately 78.4% of the loss of SPX in the third
quarter of 2023, 86.3% in the third quarter of 2022 and 80.7% in
the second quarter of 2023. The Company's current share of the
operating loss is a result of the high value of the Company's
initial contribution. Although the Company's equity ownership of
SPX was approximately 78.4% at September 30, 2023, the Company did
not recognize a share of loss in SPX in the third quarter of 2023
because the value of its investment is carried at nil on the
consolidated statements of financial position precluding further
loss recognition under the relevant accounting standards.
Cash flow from operating activities in the third quarter of 2023
was ($4.1) million, compared to ($2.5) million in the third quarter
of 2022 and ($4.0) million in the second quarter of 2023.
From January 1, 2023 to date, the Company received net proceeds of
$9.0 million from the sale of shares, including through the
exercise of warrants and stock options.
Non-IFRSSummary
of Financial
Performance Measures
Certain financial information presented in this press release is
not prescribed by IFRS. These non-IFRS financial performance
measures are included because management has used the information
to analyze the business performance and financial position of POET.
These non-IFRS financial measures are intended to provide
additional information only and do not have any standardized
meaning under IFRS and may not be comparable to similar measures
presented by other companies. These non-IFRS financial measures
should not be considered in isolation or as a substitute for
measures of performance prepared in accordance with IFRS.The
following is a summary of the Company's operations over the five
quarters ending September 30, 2023. This information should be read
in conjunction with the Company's financial statements filed on
Sedar + on November 14, 2023.
POET TECHNOLOGIES INC.
PROFORMA[SAA2] - NON-IFRS AND
[SAA3]IFRSSUMMARY PRESENTATION OF OPERATIONS
(All figures are in U.S. Dollars)
|
Sep
30/23
|
Jun
30/23
|
Mar
31/23
|
Dec
31/22
|
Sep
30/22
|
|
|
|
|
|
|
Sales
|
$
-
|
$
177,390
|
$
180,836
|
$
199,559
|
$
232,928
|
Research and development
|
2,043,264
|
2,036,953
|
2,316,475
|
2,745,886
|
1,884,767
|
Depreciation and amortization
|
508,484
|
462,743
|
445,044
|
341,017
|
336,446
|
Professional fees
|
273,905
|
255,094
|
313,404
|
430,668
|
203,778
|
Wages and benefits
|
640,241
|
655,066
|
677,924
|
665,682
|
646,349
|
Impact of joint venture
|
-
|
-
|
-
|
405,471
|
(116,747)
|
Stock-based compensation
|
1,251,648
|
697,690
|
1,202,018
|
1,588,706
|
880,796
|
General expense, rent and
facility
|
429,457
|
502,707
|
566,768
|
359,062
|
484,559
|
Interest expense
|
34,890
|
11,214
|
10,531
|
11,610
|
11,707
|
Other (income), including
interest
|
(45,448)
|
(57,454)
|
(78,041)
|
(68,592)
|
(57,429)
|
Net loss, before taxes
|
$
5,136,441
|
$
4,386,623
|
$
5,273,287
|
$
6,279,951
|
$
4,041,298
|
Net loss per share
|
$
(0.13)
|
$
(0.11)
|
$
(0.14)
|
$
(0.17)
|
$
(0.11)
|
About POET
Technologies Inc.
POET
is a design and development company offering integration solutions
based on the POET Optical Interposerâ„¢, a novel platform that allows
the seamless integration of electronic and photonic devices into a
single multi-chip module using advanced wafer-level semiconductor
manufacturing techniques and packaging methods. POET's Optical
Interposer eliminates costly components and labor-intensive
assembly, alignment, burn-in and testing methods employed in
conventional photonics. The cost-efficient integration scheme and
scalability of the POET Optical Interposer brings value to any
device or system that integrates electronics and photonics,
including some of the highest growth areas of computing, such as
Artificial Intelligence (AI), the Internet of Things (IoT),
autonomous vehicles and high-speed networking for cloud service
providers and data centers. POET is headquartered in Toronto, with
operations in Allentown, PA, Shenzhen, China and Singapore. More
information may be obtained at www.poet-technologies.com.
Forward-Looking
Statements
This press release contains
"forward-looking information" (within the meaning of applicable
Canadian securities laws) and "forward-looking statements" (within
the meaning of the U.S. Private Securities Litigation Reform Act of
1995, including statements regarding expectations for growth in
revenue). Such statements or information are identified with words
such as "anticipate", "believe", "expect", "plan", "intend",
"potential", "estimate", "propose", "project", "outlook", "foresee"
or similar words suggesting future outcomes or statements regarding
an outlook. Such information and statements include statements
related to the Company's most recently completed fiscal quarter and
its expectations for commercializing its technology and products,
the ongoing offering and efforts to enhance sales and customer
acquisition and the other elements of its growth
strategy.
Such forward-looking information or
statements are based on a number of risks, uncertainties and
assumptions which may cause actual results or other expectations to
differ materially from those anticipated and which may prove to be
incorrect. Important factors that could affect performance and
cause results to differ materially from those expressed or implied
in the forward-looking information or statements are described in
the "Risk Factors" section in the Company's Annual Report on Form
20-F for the fiscal year ended December 31, 2022, as updated from
time to time in the Company's filings with the U.S. Securities and
Exchange Commission.
These factors include, but are not
limited to, the Company's ability to raise capital (whether in the
ongoing offering or otherwise), market conditions, the failure of
the Company's products to meet performance requirements, the
failure to produce products on a timely basis or at all, the
failure of the Company's optical engine or light source products to
be incorporated into its customers' products, the failure of its
customers' products to achieve market penetration, and operational
risks including the ability to attract key personnel. Although the
Company believes that the expectations reflected in the
forward-looking information or statements are reasonable,
prospective investors in the Company's securities should not place
undue reliance on forward-looking information and statements
because the Company can provide no assurance that such expectations
will prove to be correct. Forward-looking information and
statements contained in this press release are as of the date of
this press release and the Company assumes no obligation to update
or revise this forward-looking information and statements except as
required by law.
Contacts:
Neither TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
120 Eglinton Avenue, East, Suite 1107,
Toronto, ON, M4P 1E2- Tel: 416-368-9411 - Fax:
416-322-507